TrialCancer2015

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.

Yi-Bin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.